Skip to main content
. 2014 Jul 29;7(1):17. doi: 10.1186/1939-4551-7-17

Figure 1.

Figure 1

Reduce levels of circulating free IgE by interacting with omalizumab to form immune complexes prevents IgE interaction with cell surface high-affinity IgE receptors (FcóϵRI) expressed on dendritic cells, mast cells and basophils and also results in inhibition of FcϵRI expression to enhance inhibitory effects on the allergic cascade.